Learn everything you need to know about successful options trading with this three-part video course. On average, they expect Madison Square Garden Sports' stock price to reach $203.17 in the next twelve months. See what's happening in the market right now with MarketBeat's real-time news feed. Kindly follow our Code of Conduct and refrain from posting any abusive, promotional or gibberish content on forum. Madison Square Garden Sports does not currently pay a dividend. View Madison Square Garden Sports' earnings history. Psychedelics Firm MindMed Receives Bullish Rating and Price Target from Canaccord, Initiates NASDAQ Uplisting, MindMed (NEO: MMED) (OTCQB: MMEDF) (FRA: BGHM), stated MindMed Co-Founder and Co-CEO JR Rahn, Cannabis Countdown: Top 10 Marijuana and Psychedelic Stock News Stories of the Week, ‘Psychedelic Capitalism’ a New Concern as the Psychedelics Industry Takes Shape, The Power and Influence of the Psychedelic Scientist Celebrity, https://www.youtube.com/watch?v=uzN_jK7U7g8, Red White & Bloom Closes $25 Million Bought Deal, With Fully Exercised Over-Allotment Option, Cannabis Countdown: Top 10 Marijuana and Psychedelics Industry News Stories of the Week.
BOARDS. Canaccord will also be tasked with evaluating potential M&A opportunities for the psychedelics company. We take the quality of the messages posted on forum as seriously as our articles. There are currently 6 buy ratings for the stock, resulting in a consensus recommendation of "Buy." Fundamental company data provided by Morningstar and Zacks Investment Research. MindMed to Uplist on NASDAQ Following Compass Pathways IPO. Therefore, with this study we will try to understand and compare the altered states of consciousness induced by the two substances and identify potential medicines for patients,” stated Dr. Miri Halperin Wernli, President of MindMed. In the past three months, Madison Square Garden Sports insiders have not sold or bought any company stock. 6 Wall Street analysts have issued ratings and price targets for Madison Square Garden Sports in the last 12 months. To see all exchange delays and terms of use please see disclaimer. Learn more.
Identify stocks that meet your criteria using seven unique stock screeners. Madison Square Garden Sports Corp. (NASDAQ:MSGS) announced its quarterly earnings results on Monday, May, 11th. As part of the company’s plan to expand its American shareholder base, MindMed announced on Monday that it applied with the NASDAQ to list its shares to the national U.S. exchange. MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Canaccord analyst Tania Gonsalves assigned a “Speculative Buy” rating on shares of MindMed while slapping a bullish CDN $1.75 price target on MMED stock. The lighter blue line represents the stock's consensus price target.